EX-99.1 2 ea028362201ex99-1.htm PRESS RELEASE ANNOUNCES FINANCIAL RESULTS FOR THE 2025 FISCAL YEAR DATED MARCH 26, 2026 Exhibit 99.1 Alpha Cognition Inc. Nasdaq: ACOG 1452 Hughes Road, Ste. 200 Grapevine, TX 65051 www.alphacognition.com info@alphacognition.com Alpha Cognition Inc. Reports Fiscal 2025 Financial Results and Provides Operational Update Alpha Cognition generated fourth quarter 2025 ZUNVEYL net product revenue of $2.5 million, contributing to full year 2025 total revenue of $10.2 million Fourth quarter bottles dispensed increased 62% quarter-over-quarter to 4,941, with December representing the strongest month since launch Executed second national PBM contract and initiating three studies to further support ZUNVEYL’s positioning in long-term care Alzheimer’s patients Cash and cash equivalents totaled $66 million at year-end 2025, supporting the company’s continued target of operating profitability in 2027 Company to host conference call and webcast today, March 26, at 4:30 p.m. ET VANCOUVER, B.C., Grapevine, TX, March 26, 2026. Alpha Cognition Inc. (ACOG: NASDAQ) (“Alpha Cognition”, “ACI”, or the “Company”), a biopharmaceutical co…
Open exhibit ↗Current Report · Items 2.02, 9.01 · 8-K
Alpha Cognition Inc.
ACOGNASDAQEQUITYCurrent
Results of Operations and Financial Condition
Item Results 2.02 of Operation and Financial Condition On March 26, 2026, the Company issued a press release announcing its financial and operational results for the year ended December 31, 2025 and announcing a management call to discuss the financial results (the “ Press Release ”). A copy of the Press Release is attached hereto as Exhibit 99.1 and is incorporated herein by reference.…
Company context
Current securities
Historical securities (1)
Disclosure sections
Item 2.02Item 2.02 - Results of Operations
Item Results
2.02 of Operation and Financial Condition
On
March 26, 2026, the Company issued a press release announcing its financial and operational results for the year ended December 31, 2025
and announcing a management call to discuss the financial results (the “ Press Release ”). A copy of the Press Release
is attached hereto as Exhibit 99.1 and is incorporated herein by reference.
In
accordance with General Instruction B.2 of Form 8-K, the information in this Form 8-K (including Exhibit 99.1) is being “furnished,”
and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “ Exchange
Act ”), or otherwise subject to the liabilities of that Section nor shall they be deemed incorporated by reference in any filing
made by the Company under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference
in such a filing.